• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [17116 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     National Institute for Health and Care Excellence (NICE) Therapeutic sialendoscopy. NICE interventional procedures guidance 218
2007     Adelaide Health Technology Assessment (AHTA) Implantable miniature telescope for macular degeneration
2007     National Institute for Health and Care Excellence (NICE) Lower limb deep vein valve reconstruction for chronic deep venous incompetence. NICE interventional procedures guidance 219
2007     National Institute for Health and Care Excellence (NICE) Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium. NICE interventional procedures guidance 216
2007     National Institute for Health and Care Excellence (NICE) Laparoscopic nephrolithotomy and pyelolithotomy. NICE interventional procedures guidance 212
2007     National Institute for Health and Care Excellence (NICE) Microwave ablation of hepatocellular carcinoma. NICE interventional procedures guidance 214
2007     National Institute for Health and Care Excellence (NICE) Radiofrequency-assisted liver resection. NICE interventional procedures guidance 211
2007     Institute for Clinical Evaluative Sciences (ICES) Quality assessment of administrative data (QuAAD): an opportunity for enhancing Ontario's health data
2007     National Institute for Health and Care Excellence (NICE) Laparoscopic insertion of peritoneal dialysis catheter. NICE interventional procedures guidance 208
2007     University of York Psychosocial interventions for non-professional carers of people with Parkinson's Disease: a scoping review
2007     Institute for Clinical Evaluative Sciences (ICES) The Ontario Wait Time Strategy: no evidence of an adverse impact on other surgeries
2007     National Institute for Health and Care Excellence (NICE) Implantation of accommodating intraocular lenses for cataract. NICE interventional procedures guidance 209
2007     Agency for Healthcare Research and Quality (AHRQ) Tool for evaluating core elements of hospital disaster drills
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review
2007     HAYES, Inc. Extracorporeal apheresis for conditions affecting the circulatory system and blood
2007     VA Technology Assessment Program (VATAP) Computerized tomography colonography
2007     Institute for Clinical Evaluative Sciences (ICES) Diagnostic services in Ontario: descriptive analysis and jurisdictional review
2007     National Institute for Health and Care Excellence (NICE) Injectable bulking agents for faecal incontinence. NICE interventional procedures guidance 210
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost-effectiveness of immunoprophylaxis against respiratory syncytial virus with palivizumab in children
2007     VA Technology Assessment Program (VATAP) Stereotactic radiosurgery: update
2007     National Institute for Health and Care Excellence (NICE) Laparoscopic distal pancreatectomy. NICE interventional procedures guidance 204
2007     VA Technology Assessment Program (VATAP) Systematic reviews for patient-centered care
2007     National Institute for Health and Care Excellence (NICE) Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction. NICE interventional procedures guidance 205
2007     VA Technology Assessment Program (VATAP) Systematic reviews of strategies for changing clinician behavior to improve patient outcomes
2007     National Institute for Health and Care Excellence (NICE) Palliative photodynamic therapy for advanced oesophageal cancer. NICE interventional procedures guidance 206
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for acquisition of new technologies (GANT)
2007     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and appropriate use of interventions in the management of climacterium-related problems]
2007     Andalusian Health Technology Assessment Area (AETSA) Update of the guide for the introduction of new drugs (GINF)
2007     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of natalizumab for multiple sclerosis: an evidence review of the submission from Biogen
2007     Agency for Healthcare Research and Quality (AHRQ) Treatment of primary and secondary osteoarthritis of the knee
2007     Health Technology and Policy Unit (HTPU) Double Balloon Endoscopy/Enteroscopy (DBE) for the diagnosis and treatment of conditions of the small intestine
2007     Agency for Healthcare Research and Quality (AHRQ) Collection and use of cancer family history in primary care
2007     Health Technology and Policy Unit (HTPU) Photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH)
2007     Agency for Healthcare Research and Quality (AHRQ) Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
2007     Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: a critical analysis of quality improvement strategies. Volume 7 - care coordination
2007     Agency for Healthcare Research and Quality (AHRQ) Consumer-oriented strategies for improving health benefit design: an overview
2007     Agency for Healthcare Research and Quality (AHRQ) Compendia for coverage of off-label uses of drugs and biologics in an anticancer chemotherapeutic regimen
2007     Agency for Healthcare Research and Quality (AHRQ) Decompression therapy for the treatment of lumbosacral pain
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Electronic patient record at an osteoporotic outpatient department - a Health Technology Assessment]
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Lubiprostone
2007     Agency for Healthcare Research and Quality (AHRQ) Applicability of the evidence regarding intensive glycemic control and self-monitored blood glucose to Medicare patients with Type 2 diabetes
2007     National Institute for Health and Care Excellence (NICE) Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. NICE technology appraisal guidance 131
2007     Agency for Healthcare Research and Quality (AHRQ) Esophageal doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients
2007     National Institute for Health and Care Excellence (NICE) Bortezomib monotherapy for relapsed multiple myeloma. NICE technology appraisal guidance 129
2007     Agency for Healthcare Research and Quality (AHRQ) Home diagnosis of obstructive sleep apnea-hypopnea syndrome
2007     National Institute for Health and Care Excellence (NICE) Stapled haemorrhoidopexy for the treatment of haemorrhoids. NICE technology appraisal guidance 128
2007     Agency for Healthcare Research and Quality (AHRQ) Genetic tests for non-cancer diseases/conditions: a horizon scan
2007     National Institute for Health and Care Excellence (NICE) Pemetrexed for the treatment of non-small-cell lung cancer. NICE technology appraisal guidance 124
2007     National Institute for Health and Care Excellence (NICE) Varenicline for smoking cessation. NICE technology appraisal guidance 123
2007     Institute for Clinical and Economic Review (ICER) Intensity modulated radiation therapy (IMRT) for localized prostate cancer
2007     National Institute for Health and Care Excellence (NICE) Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. NICE technology appraisal guidance 121
2007     National Institute for Health and Care Excellence (NICE) Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 119
2007     National Institute for Health and Care Excellence (NICE) Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. NICE technology appraisal guidance 117
2007     NIHR Health Technology Assessment programme A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines
2007     New Zealand Health Technology Assessment (NZHTA) Risk factors for breast cancer in women: a systematic review of the literature
2007     National Institute for Health and Care Excellence (NICE) Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance 114
2007     National Institute for Health and Care Excellence (NICE) Naltrexone for the management of opioid dependence. NICE technology appraisal guidance 115
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2007     National Institute for Health and Care Excellence (NICE) Gemcitabine for the treatment of metastatic breast cancer. NICE technology appraisal guidance 116
2007     Medical Advisory Secretariat (MAS) Multidetector computed tomography for coronary artery disease screening in asymptomatic populations: an evidence-based analysis
2007     NIHR Health Technology Assessment programme Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007     Medical Advisory Secretariat (MAS) Anal dysplasia screening: an evidence-based analysis
2007     Medical Advisory Secretariat (MAS) Low-density lipoprotein apheresis: an evidence-based analysis
2007     NIHR Health Technology Assessment programme Strontium ranelate for the prevention of osteoporotic fractures in post-menopausal women with osteoporosis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of costeffectiveness
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Effectiveness of magnetic resonance imaging (MRI) screening for women at high risk of breast cancer
2007     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling
2007     NIHR Health Technology Assessment programme A comparison and discussion of the methods, findings, adaptability and decisions resulting from two reviews of vision screening in children undertaken in the UK and Germany
2007     NIHR Health Technology Assessment programme A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder
2007     NIHR Health Technology Assessment programme Taxanes for the adjuvant treatment early breast cancer: systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models
2007     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of off-label use of atypical antipsychotics
2007     NIHR Health Technology Assessment programme Contamination in trials of educational interventions
2007     New Zealand Health Technology Assessment (NZHTA) Effectiveness and cost-effectiveness of population screening for colorectal cancer: a systematic review of the literature (revised edition)
2007     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression
2007     NIHR Health Technology Assessment programme Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers
2007     NIHR Health Technology Assessment programme Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007     NIHR Health Technology Assessment programme A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.
2007     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high grade glioma: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Drug-eluting stents: a systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model
2007     NIHR Health Technology Assessment programme Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness
2007     Adelaide Health Technology Assessment (AHTA) Nanomedicine
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2007     Health Council of the Netherlands Gezondheidsraad (GR) Bitumen (vapour and aerosol); Health-based recommended occupational exposure limit
2007     Agency for Health Technology Assessment in Poland (AHTAPol) Cost-effectiveness analysis of PET-CT positron emission tomography and the diagnostic technologies financed from public sources in oncological diagnostics in Poland
2007     Adelaide Health Technology Assessment (AHTA) B-type natriuretic peptide assays in the diagnosis of heart failure. Part A: in the hospital emergency setting. Part B: in the non-hospital setting
2007     NIHR Health Technology Assessment programme Abatacept for the treatment of refractory rheumatoid arthritis
2007     Penn Medicine Center for Evidence-based Practice (CEP) Peri-operative blood conservation in adults - an evidence-based protocol
2007     Adelaide Health Technology Assessment (AHTA) Genetic testing for congenital long QT syndrome
2007     Penn Medicine Center for Evidence-based Practice (CEP) Dexmedetomidine in awake craniotomy
2007     Adelaide Health Technology Assessment (AHTA) DNA microarrays
2007     Penn Medicine Center for Evidence-based Practice (CEP) Laminar flow in operating rooms to reduce surgical site infections
2007     Adelaide Health Technology Assessment (AHTA) EasyOne™ spirometer for the diagnosis and management of chronic respiratory disease and asthma
2007     Penn Medicine Center for Evidence-based Practice (CEP) Skin antiseptics to prevent surgical site infections
2007     Adelaide Health Technology Assessment (AHTA) MRI guided high intensity focused ultrasound for the non-invasive treatment of symptomatic uterine fibroids
2007     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for medical inpatients